Fierce Biotech1d
Avidity's latest DMD data drop assuages safety concerns for RNA-based asset: analyst
After some earlier data sparked questions from analysts, Avidity Biosciences has released more data for its RNA-based ...
Avidity Biosciences announces del-zota topline data from EXPLORE44 trial
Avidity Biosciences (RNA) announced del-zota topline data from the Phase 1/2 EXPLORE44 trial in people living with Duchenne muscular dystrophy ...
Avidity Biosciences announces ‘positive’ data from Phase 1/2 EXPLORE44 trial
Avidity Biosciences (RNA) announced positive del-zota topline data from the Phase 1/2 EXPLORE44 trial in people living with Duchenne muscular ...
European Medical Journal5d
Rare Anti-HMGCR-Induced Immune-Mediated Necrotising Myopathy: A Case Report and Literature Review
An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...